Shuimu BioSciences

About:

Shuimu BioSciences provides one-stop solutions for cryo-EM-Powered drug discovery.

Website: https://shuimubio.com/

Twitter/X: ShuimuBio

Top Investors: Gaorong Capital, Puhua Capital, BOHE Angel Fund

Description:

Shuimu harnesses the power of cryo-EM and Artificial Intelligence to help pharma and biotech companies discover and develop novel therapeutics faster and better, breaks new ground to develop precision medicines for the most challenging diseases on our planet. With eight 300kv Cryo-EM’s in house, proprietory GraFuture technologies, AI driven data processing and modeling platforms, Shuimu is your best partner with one-stop solutions in structure based drug and therapeutic innovation, from sequence to structure.

Total Funding Amount:

40M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-12-07

Contact Email:

Chunlong(AT)shuimubio.com

Founders:

Allen Chunlong Guo, Hongwei Wang

Number of Employees:

11-50

Last Funding Date:

2022-04-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai